Quality of Life After Breast Cancer Surgery

NCT ID: NCT06761196

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-02

Study Completion Date

2035-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery.

Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Surgery Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

The quality of life measured with different scales (BREAST-Q, EORTC QLQ C30 and BR42)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 or over
* Patient with breast cancer of any stage (including in situ) or healthy individual at high personal risk.
* Patient requiring breast surgery under general anesthesia, whether for therapeutic or prophylactic purposes.
* Patient capable, in the opinion of the investigator, of complying with the requirements and restrictions of the study.
* Patient with a computer, tablet or smartphone connected to the Internet.
* Patient followed in the center on a regular basis according to standard recommendations.

Exclusion Criteria

* Patient requiring surgical intervention under local anesthesia only.
* Patient requiring surgery for the installation or removal of an chemotherapy implantable port only.
* Patients with a history of cancer other than breast cancer. Patients with a history of cancer more than three years old are eligible if they are treated and considered cured. Patients with a history of cervical carcinoma in situ or non-melanoma skin carcinoma are eligible.
* Impossibility of being subject to regular monitoring for geographical, social or psychological reasons.
* Patient under protective measure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier de Colmar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpitaux Civils de Colmar

Colmar, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Massimo LODI, MD

Role: CONTACT

0033389124171

Magali EYRIEY

Role: CONTACT

0033389124810

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Massimo Lodi, MD

Role: primary

0033389124171

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02572-45

Identifier Type: OTHER

Identifier Source: secondary_id

HCC-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.